Markus Sieger - Net Worth and Insider Trading

Markus Sieger Net Worth

The estimated net worth of Markus Sieger is at least $217,419 dollars as of 2024-05-25. Markus Sieger is the Director of Cyclo Therapeutics Inc and owns about 161,051 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $217,419. Details can be seen in Markus Sieger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Markus Sieger has not made any transactions after 2023-04-20 and currently still holds the listed stock(s).

Transaction Summary of Markus Sieger

To

Markus Sieger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Markus Sieger owns 1 companies in total, including Cyclo Therapeutics Inc (CYTH) .

Click here to see the complete history of Markus Sieger’s form 4 insider trades.

Insider Ownership Summary of Markus Sieger

Ticker Comapny Transaction Date Type of Owner
CYTH Cyclo Therapeutics Inc 2023-04-20 director

Markus Sieger Latest Holdings Summary

Markus Sieger currently owns a total of 1 stock. Markus Sieger owns 161,051 shares of Cyclo Therapeutics Inc (CYTH) as of April 20, 2023, with a value of $217,419.

Latest Holdings of Markus Sieger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CYTH Cyclo Therapeutics Inc 2023-04-20 161,051 1.35 217,419

Holding Weightings of Markus Sieger


Markus Sieger Form 4 Trading Tracker

According to the SEC Form 4 filings, Markus Sieger has made a total of 6 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 59,881 shares on April 20, 2023, which cost Markus Sieger around $42,516.

Insider Trading History of Markus Sieger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Markus Sieger Trading Performance

GuruFocus tracks the stock performance after each of Markus Sieger's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Markus Sieger is 27.81%. GuruFocus also compares Markus Sieger's trading performance to market benchmark return within the same time period. The performance of stocks bought by Markus Sieger within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Markus Sieger's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Markus Sieger

Average Return

Average return per transaction

Outperforming Transactions

1 out of 6 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 15.93
Relative Return to S&P 500(%) 15.09

Markus Sieger Ownership Network

Ownership Network List of Markus Sieger

No Data

Ownership Network Relation of Markus Sieger


Markus Sieger Owned Company Details

What does Cyclo Therapeutics Inc do?

Who are the key executives at Cyclo Therapeutics Inc?

Markus Sieger is the director of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and SVP for Medical Affairs Sharon Hemond Hrynkow .

Cyclo Therapeutics Inc (CYTH) Insider Trades Summary

Over the past 18 months, Markus Sieger made 1 insider transaction in Cyclo Therapeutics Inc (CYTH) with a net purchase of 59,881. Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. , a net purchase of 299,402 shares made by N Scott Fine , and a net purchase of 59,881 shares made by Francis Patrick Ostronic .

In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,449,105 shares were bought by its insiders, resulting in a net purchase of 4,449,105 shares.

Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclo Therapeutics Inc Insider Transactions

No Available Data

Markus Sieger Mailing Address

Above is the net worth, insider trading, and ownership report for Markus Sieger. You might contact Markus Sieger via mailing address: Beutstweg 12, Ch-8032, Zurich V8 000000000.

Discussions on Markus Sieger

No discussions yet.